IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Wednesday's ETF Movers: SLVR, BUG
In trading on Wednesday, the Sprott Silver Miners & Physical Silver ETF is outperforming other ETFs, up about 4.4% on the day.
Is the Memory Supercycle Peak Near for Micron and SK Hynix?
Key PointsSoaring memory prices have lifted the shares of Micron Technology and SK Hynix to stratospheric heights.
Here’s how much Americans rely on Social Security — at all income levels
Social Security is really important for older Americans. It needs to be tweaked, not restructured.
Ex-Chief Economic Advisor Backs GDP Figure, Says New Methodology "Cutting Edge"
Krishnamurthy Subramanian dismissed the Opposition's charge that the government deliberately revised last year's GDP numbers downward, so that this year's growth rate would be artificially inflated.
NatWest offers a £500 Premier current account switching bonus - but are you rich enough to get it?
NatWest matches a similar Premier bonus from HSBC, but which account is better value? We look at what Premier accounts offer and whether it's worth signing up.
Tech Update: Howden Re Offers Property-Level Modeling for SRCC Risks
Howden Re, the reinsurance arm of insurance broker Howden, is partnering with the modeling company Synthetik Insurance Technologies, to launch an analytical tool designed to help insurers and…